文献
J-GLOBAL ID:201902258066797194
整理番号:19A1100262
JALSG AML201研究で登録されたT(8;21)を有するAML患者におけるASXL2およびZBTB7A変異およびC末端切断RUNX1-RUNX1T1発現の臨床的意義【JST・京大機械翻訳】
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study
著者 (26件):
Kawashima Naomi
(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan)
,
Akashi Akimi
(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan)
,
Nagata Yasunobu
(Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan)
,
Nagata Yasunobu
(Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA)
,
Kihara Rika
(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan)
,
Ishikawa Yuichi
(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan)
,
Asou Norio
(Department of Hematology, International Medical Center, Saitama Medical University, Hidaka, Japan)
,
Ohtake Shigeki
(Kanazawa University, Kanazawa, Japan)
,
Miyawaki Shuichi
(Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan)
,
Sakura Toru
(Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan)
,
Ozawa Yukiyasu
(Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan)
,
Usui Noriko
(Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan)
,
Kanamori Heiwa
(Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan)
,
Ito Yoshikazu
(Department of Hematology, Tokyo Medical University, Tokyo, Japan)
,
Imai Kiyotoshi
(Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan)
,
Suehiro Youko
(Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan)
,
Kitamura Kunio
(Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan)
,
Sakaida Emiko
(Department of Hematology, Chiba University Hospital, Chiba, Japan)
,
Takeshita Akihiro
(Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan)
,
Suzushima Hitoshi
(Department of Hematology, Kumamoto Shinto General Hospital, Kumamoto, Japan)
,
Naoe Tomoki
(National Hospital Organization Nagoya Medical Center, Nagoya, Japan)
,
Matsumura Itaru
(Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka, Japan)
,
Miyazaki Yasushi
(Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan)
,
Ogawa Seishi
(Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan)
,
Kiyoi Hitoshi
(Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan)
,
for the Japan Adult Leukemia Study Group (JALSG)
資料名:
Annals of Hematology
(Annals of Hematology)
巻:
98
号:
1
ページ:
83-91
発行年:
2019年
JST資料番号:
W4037A
ISSN:
0939-5555
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)